Document is current
Any future updates will be listed below
-
Authors
Rusiecka, Olga M.
Molica, Filippo
Clochard, Linda
Van Campenhout, Raf
De Groof, Timo W. M.
Bes, Viviane
Devoogdt, Nick
Muyldermans, Serge
Vinken, Mathieu
Kwak, Brenda R.
-
Funding
Funding for this research was provided by:
Gabbiani fund
Research Foundation Flanders (G020018N, G020018N)
Flemish Government
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030_212291/1)
University of Geneva
- License Information
-
More Information
Article History
Received: 6 November 2024
Accepted: 2 July 2025
First Online: 23 July 2025
Declarations
:
: All experimental protocols involving mice were reviewed and approved by the Swiss cantonal and federal veterinary authorities (number 33646).
: Not applicable.
: RVC, TWMDG, ND and MV are co-inventors on a pending EU patent application EP23158621, which covers the use of Panx1-targeting nanobodies. The other authors declare no conflict of interest.
